[1]
Perletti, G., Monti, E., Marras, E., Cleves, A., Magri, V., Trinchieri, A. and Rennie, P. 2015. Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis. Archivio Italiano di Urologia e Andrologia. 87, 2 (Jul. 2015), 121-129. DOI:https://doi.org/10.4081/aiua.2015.2.121.